Bristol Myers Squibb (NYSE:BMY) has named Christopher Boerner as their new Chair of the Board of Directors and CEO. Boerner, who is set to take over as Chair in April 2024, will assume the role of CEO from November 1.
What Happened: The pharmaceutical giant announced on October 31 that Boerner was unanimously elected to succeed Giovanni Caforio, M.D., as Chair of the Board. Caforio will retire after 23 years of service to the company. Boerner, previously named Executive Vice President, Chief Operating Officer, and CEO-elect, will step into his new role as CEO from the start of November.
See Also: Bristol Myers Squibb Analysts Slash Their Forecasts Following Q3 Results
Both Boerner and Caforio expressed their gratitude for the opportunity to serve Bristol Myers Squibb. Theodore R. ...